Evidence map›Paper›PMID 32735179›Full record

ArticleIntegrative cancer therapies

Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.

Ming Sun, Renge Bu, Bin Zhang, Yaming Cao, Chengyang Liu, Wenyan Zhao

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Orchestration of Tumor-Associated Macrophages in the Tumor Cell-Macrophage-CD8International journal of biological sciences · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Anti-Influenza Effect and Mechanisms of Lentinan in an ICR Mouse Model.Frontiers in cellular and infection microbiology · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ming SunShengjing Hospital of China Medical University, Shenyang, China.ORCID 0000-0002-4343-2394
Renge BuShengjing Hospital of China Medical University, Shenyang, China.
Bin ZhangShengjing Hospital of China Medical University, Shenyang, China.
Yaming CaoCollege of Basic Medical Sciences, China Medical University, Shenyang, China.
Chengyang LiuPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wenyan ZhaoShengjing Hospital of China Medical University, Shenyang, China.
China Medical University · CNUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LentinanUrinary Bladder NeoplasmsAnimalsCD8-Positive T-LymphocytesImmunomodulationMiceT-Lymphocytes, RegulatoryLentinanbladder cancergemcitabineimmunomodulationlentinan

Identifiers

PMID32735179
PMCPMC7401035
OpenAlexW3046563604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.